Pulmonology
Conference Coverage
Asthma ED visits predict failed housing inspections
Asthma ED visits increased more than 1 year before a failed HUD inspection but were not elevated at housing units that passed inspection.
Feature
You and the skeptical patient: Who’s the doctor here?
“I spoke to him on many occasions about the dangers of COVID, but he just didn’t believe me.”
From the Journals
New deep dive into Paxlovid interactions with CVD meds
The review tackles potential drug-drug interactions with the antiviral drug and today’s most commonly prescribed cardiovascular drugs.
Opinion
The marked contrast in pandemic outcomes between Japan and the United States
Over time Japan has the least cumulative deaths per capita of any major country in the world.
Latest News
New screening tool identifies asthma risk in toddlers
Unique classification of wheeze symptoms before age 3 may predict asthma at 5.
News from the FDA/CDC
FDA: Newborns protected by whooping cough vaccine
“This is the first vaccine approved specifically for use during pregnancy to prevent a disease in young infants whose mothers are vaccinated...
Livin' on the MDedge
Meet our newest genetically engineered frenemy, herpes
Plus: Cooking and cleaning your way to air pollution, dying to become a tree, and thawing out “COVID-frozen” goals.
Feature
Increasing primary care doctors’ knowledge of IPF could speed up diagnoses, suggests white paper
Nonspecific symptoms of IPF may prompt primary care providers to pursue other assessment pathways.
News from the FDA/CDC
CDC warns of enterovirus strain linked to polio-like condition
The advisory also urged providers to “strongly consider AFM in patients with acute flaccid limb weakness, especially after respiratory illness or...
Feature
Many young kids with COVID may show no symptoms
The relationship between symptoms and viral load also differed between adults and young children in a new study.
Latest News
Vaccine hope now for leading cause of U.S. infant hospitalizations: RSV
New data show a universal immunization strategy with nirsevimab could substantially reduce the health and economic burden for U.S. infants in...